Navigation Links
First drug candidate from NIH program acquired by biopharmaceutical company
Date:7/9/2014

ructural change may lessen sickling-related complications in patients.

Sickle cell disease disproportionately affects African-Americans and is considered both rare and neglected in the United States. African-Americans with sickle cell often face significant health disparities in clinical care. Life expectancy for people with sickle cell disease is only to mid- to late 40s.

Prior to AesRx's collaboration with TRND researchers, and despite promising data on Aes-103, the company had difficulty securing private financing because potential investors lacked interest in funding an early-stage project that was considered too risky. AesRx did not have the resources to complete preclinical and early clinical development.

Currently, the only drug approved by the U.S. Food and Drug Administration (FDA) to treat sickle cell disease is hydroxyurea, a drug initially developed to treat cancer. However, the clinical utility of hydroxyurea is limited. Many individuals with sickle cell disease either do not respond to the drug, or they may experience undesirable side effects.

"Sickle cell was the first disease to ever have its molecular cause discovered more than 65 years ago and now a potential treatment based on that discovery has at last been developed," said NCATS Director Christopher P. Austin, M.D. "This success validates the NCATS model, which is based on a novel collaborative approach that de-risks intervention development programs to enable private-sector investment. We look forward to applying this model to the thousands of rare diseases that are currently untreatable so that we realize the NCATS mission of getting more treatments to more patients more quickly."

TRND researchers signed a collaborative agreement with AesRx in 2010 and established a project team made up of NCATS and AesRx scientists as well as a leading sickle cell disease clinical researcher at the National Heart, Lung, and Blood Institute (NHLBI). Other key p
'/>"/>

Contact: NCATS Office of Communications
spencerg@mail.nih.gov
301-435-0888
NIH/National Center for Advancing Translational Sciences (NCATS)
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. Kessler Foundation implements Ekso Bionics first commercial robotic exoskeleton
2. Research reveals first evidence of hunting by prehistoric Ohioans
3. First model of how buds grow into leaves
4. American College of Rheumatology releases first classification criteria for polymyalagia rheumatica
5. Ottawa researchers to lead world-first clinical trial of stem cell therapy for septic shock
6. First complete full genetic map of promising energy crop
7. FirstMark Announces New Hire Jay Houtman as Southeast Regional Sales Manager
8. FirstMark Exhibiting at the Inaugural Atlanta Clinical Cardiology Update
9. New technology tracks sparrow migration for first time from California to Alaska
10. First mass extinction linked to marine anoxia
11. Scientists complete first-ever emperor penguin count from space
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
First drug candidate from NIH program acquired by biopharmaceutical company
(Date:9/22/2014)... native species have vanished from tropical islands because ... have discovered how fossils can be used to ... in organic materials found in fossil bones, which ... to a new study available online and in ... Herpetology . Pre-human island ecosystems provide vital clues ...
(Date:9/22/2014)... grass in recent years has been identified as the ... the aroma also summons beneficial insects to the rescue. ... signals the environment via the emission of volatile organic ... parasitic wasps to come to the plant that is ... said Dr. Michael Kolomiets, Texas A&M AgriLife Research plant ...
(Date:9/22/2014)... New Rochelle, NY, September 22, 2014Cassava, also known as ... high yields in areas of Africa, Asia, and Latin ... With the availability of novel enzymes and processes designed ... then be used to produce sweeteners such as glucose, ... alternative to corn, as described in a Review article ...
Breaking Biology News(10 mins):Answer to restoring lost island biodiversity found in fossils 2Mown grass smell sends SOS for help in resisting insect attacks, researchers say 2Mown grass smell sends SOS for help in resisting insect attacks, researchers say 3
... potential as an eco-friendly fuel, but it is expensive ... University have moved a step closer to harnessing nature ... by Princeton chemistry professor Annabella Selloni, takes inspiration from ... di-iron hydrogenases. Selloni,s team uses computer models to figure ...
... structure in Burckhard Seelig,s lab at the University of ... of years ago, when life on earth began to ... and improved products, from detergents to foods and fuels. ... evolution in the laboratory. Working with colleague Gianluigi Veglia, ...
... - Scientists have long known that cattle produce carbon dioxide ... the cow-calf stage as a major contributor of greenhouse gases ... Journal of Animal Science , scientists estimate greenhouse gas ... show that, depending on which production system farmers used, beef ...
Cached Biology News:U. of Minn. researchers unveil first artificial enzyme created by evolution in a test tube 2In beef production, cow-calf phase contributes most greenhouse gases 2
(Date:9/23/2014)... ATCC, the premier global biological materials ... important appointments to the senior leadership team. Barbie Bigelow ... and Technology and Dr. Maryellen de Mars also joins ... Both roles are new positions at ATCC. ... at ATCC described the additions as part of a ...
(Date:9/23/2014)...  Age Defying Dermatology ® , owned and operated ... of the first clinics in the Bay Area to ... tattoo removal. The treatment safely and effectively erases tattoos ... removal has been a lengthy, painful, and all too ... opportunity to erase tattoo pigment more efficiently with far ...
(Date:9/23/2014)... 2014   GenoSpace , a precision medicine software ... to enable the broad use of genomic data in ... been awarded Phase I of a Fast Track Small ... of Health (NIH) to enable enhanced data access and ... http://photos.prnewswire.com/prnh/20140922/147649 During the past decade, ...
(Date:9/23/2014)... 2014 Healthcare professionals, patients ... convene at the Society for Integrative Oncology ... October 26-28 in Houston, Texas to discuss ... in individualized integrative cancer care. This multi-disciplinary ... nutritionists, naturopaths, acupuncturists, and other complementary care ...
Breaking Biology Technology:ATCC Announces New Appointments to its Leadership Team 2ATCC Announces New Appointments to its Leadership Team 3Age Defy Now Offers World's Most Advanced Technology for Tattoo Removal 2GenoSpace Awarded Fast Track SBIR Grant to Enable Data Access and Cohort Construction for Biorepositories 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 2International Medical Experts to Discuss Latest Integrative Oncology Research and Its Translation to Personalized Clinical Care at 11th International Conference of SIO 3
... (Nasdaq: NVAX ) today announced that it will ... to be issued after 8:00 a.m. local time Monday, March ... at 10:00 a.m. The call will be hosted by Novavax,s ... members of senior management. The dial-in number for the conference ...
... Advanced Cell Technology, Inc. ("ACT"; OTC Bulletin Board: ... of regenerative medicine, announced today that China,s State Intellectual ... to provide broad intellectual property protection in China for ... (RPE) cells from human embryonic stem cells (hESCs).   ...
... March 22, 2011 Dyadic International, Inc. ("Dyadic") ... on the discovery, development, manufacture and sale of ... enzyme and biopharmaceutical industries, announced today the introduction ... CMAX™, at the World Biofuels Markets exhibition ...
Cached Biology Technology:ACT to Be Issued Broad Patent for Human ES Cell-derived RPE Cells in China 2ACT to Be Issued Broad Patent for Human ES Cell-derived RPE Cells in China 3Dyadic International Introduces Advanced Biofuels Enzyme AlternaFuel® CMAX™ At World Biofuels Markets 2
Anti-gp120/160(SIV/mac239) Immunogen: gp120(SIV/mac239) protein (Genebank accession #M33262)...
Annexin V Binding Buffer, 10X Concentrate Buffer , 50 ml Consult technical datasheet for details....
IHC Select Anti-p53, prediluted,wild & mutant, a.a. 19-26, clone DO-7 Immunogen: Human p53 Available Date: 37775...
Feline Rhinotracheitis Virus...
Biology Products: